These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

555 related articles for article (PubMed ID: 29479437)

  • 21. Microbiome and Colorectal Cancer.
    Ahmed I; Umar S
    Curr Colorectal Cancer Rep; 2018 Dec; 14(6):217-225. PubMed ID: 33456404
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Microbial Interactions and Interventions in Colorectal Cancer.
    Van Raay T; Allen-Vercoe E
    Microbiol Spectr; 2017 Jun; 5(3):. PubMed ID: 28643625
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Identification of host gene-microbiome associations in colorectal cancer patients using mendelian randomization.
    Xiang Y; Zhang C; Wang J; Cheng Y; Wang L; Tong Y; Yan D
    J Transl Med; 2023 Aug; 21(1):535. PubMed ID: 37563724
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Colorectal cancer and gut microbiota studies in China.
    Wang Z; Dan W; Zhang N; Fang J; Yang Y
    Gut Microbes; 2023; 15(1):2236364. PubMed ID: 37482657
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Untangling determinants of gut microbiota and tumor immunologic status through a multi-omics approach in colorectal cancer.
    Zhang SL; Cheng LS; Zhang ZY; Sun HT; Li JJ
    Pharmacol Res; 2023 Feb; 188():106633. PubMed ID: 36574857
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Microbiota dysbiosis and barrier dysfunction in inflammatory bowel disease and colorectal cancers: exploring a common ground hypothesis.
    Yu LC
    J Biomed Sci; 2018 Nov; 25(1):79. PubMed ID: 30413188
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effects of gut microbiota on immune responses and immunotherapy in colorectal cancer.
    Hou X; Zheng Z; Wei J; Zhao L
    Front Immunol; 2022; 13():1030745. PubMed ID: 36426359
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Gut Microbiome in Colorectal Cancer: Clinical Diagnosis and Treatment.
    Liu Y; Lau HC; Cheng WY; Yu J
    Genomics Proteomics Bioinformatics; 2023 Feb; 21(1):84-96. PubMed ID: 35914737
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Role of Gut Microbiota in the Development and Treatment of Colorectal Cancer.
    Lin C; Cai X; Zhang J; Wang W; Sheng Q; Hua H; Zhou X
    Digestion; 2019; 100(1):72-78. PubMed ID: 30332668
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Role of Microbiome in Carcinogenesis Process and Epigenetic Regulation of Colorectal Cancer.
    Farhana L; Banerjee HN; Verma M; Majumdar APN
    Methods Mol Biol; 2018; 1856():35-55. PubMed ID: 30178245
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Novel Insights Into the Interactions Between the Gut Microbiome, Inflammasomes, and Gasdermins During Colorectal Cancer.
    Privitera G; Rana N; Scaldaferri F; Armuzzi A; Pizarro TT
    Front Cell Infect Microbiol; 2021; 11():806680. PubMed ID: 35111698
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Changes in gut microbiota and plasma inflammatory factors across the stages of colorectal tumorigenesis: a case-control study.
    Zhang Y; Yu X; Yu E; Wang N; Cai Q; Shuai Q; Yan F; Jiang L; Wang H; Liu J; Chen Y; Li Z; Jiang Q
    BMC Microbiol; 2018 Aug; 18(1):92. PubMed ID: 30157754
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Gut microbiota, inflammatory bowel disease and colorectal cancer.
    Quaglio AEV; Grillo TG; De Oliveira ECS; Di Stasi LC; Sassaki LY
    World J Gastroenterol; 2022 Aug; 28(30):4053-4060. PubMed ID: 36157114
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Gut Microbiota Manipulation as a Tool for Colorectal Cancer Management: Recent Advances in Its Use for Therapeutic Purposes.
    Perillo F; Amoroso C; Strati F; Giuffrè MR; Díaz-Basabe A; Lattanzi G; Facciotti F
    Int J Mol Sci; 2020 Jul; 21(15):. PubMed ID: 32751239
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Association of the microbiome with colorectal cancer development (Review).
    Abdulla MH; Agarwal D; Singh JK; Traiki TB; Pandey MK; Ahmad R; Srivastava SK
    Int J Oncol; 2021 May; 58(5):. PubMed ID: 33760154
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Intestinal Microbiota: Novel Personalized Cancer Immunotherapy in Colorectal Cancer.
    Azimi M; Keshavarz Shahbaz S; Mansourabadi AH; Mohamed Khosroshahi L; Pourkalhor S; Rezakhani M; Masoumi F
    Int Arch Allergy Immunol; 2022; 183(11):1147-1165. PubMed ID: 35988536
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Altered intestinal microbiota associated with colorectal cancer.
    Zhang H; Chang Y; Zheng Q; Zhang R; Hu C; Jia W
    Front Med; 2019 Aug; 13(4):461-470. PubMed ID: 31250341
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Metagenome-scale community metabolic modelling for understanding the role of gut microbiota in human health.
    Beura S; Kundu P; Das AK; Ghosh A
    Comput Biol Med; 2022 Oct; 149():105997. PubMed ID: 36055158
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Gut Dysbiosis and Intestinal Barrier Dysfunction: Potential Explanation for Early-Onset Colorectal Cancer.
    Ahmad Kendong SM; Raja Ali RA; Nawawi KNM; Ahmad HF; Mokhtar NM
    Front Cell Infect Microbiol; 2021; 11():744606. PubMed ID: 34966694
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The Colorectal Cancer Gut Environment Regulates Activity of the Microbiome and Promotes the Multidrug Resistant Phenotype of ESKAPE and Other Pathogens.
    Lamaudière MTF; Arasaradnam R; Weedall GD; Morozov IY
    mSphere; 2023 Apr; 8(2):e0062622. PubMed ID: 36847529
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 28.